Correlation Between BioAffinity Technologies and Amer Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Amer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Amer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies Warrant and Amer Bio Medica, you can compare the effects of market volatilities on BioAffinity Technologies and Amer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Amer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Amer Bio.

Diversification Opportunities for BioAffinity Technologies and Amer Bio

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioAffinity and Amer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Amer Bio Medica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amer Bio Medica and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Amer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amer Bio Medica has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Amer Bio go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Amer Bio

If you would invest  30.00  in bioAffinity Technologies Warrant on November 3, 2024 and sell it today you would earn a total of  30.00  from holding bioAffinity Technologies Warrant or generate 100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.56%
ValuesDaily Returns

bioAffinity Technologies Warra  vs.  Amer Bio Medica

 Performance 
       Timeline  
BioAffinity Technologies 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
Amer Bio Medica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amer Bio Medica has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Amer Bio is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

BioAffinity Technologies and Amer Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioAffinity Technologies and Amer Bio

The main advantage of trading using opposite BioAffinity Technologies and Amer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Amer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Bio will offset losses from the drop in Amer Bio's long position.
The idea behind bioAffinity Technologies Warrant and Amer Bio Medica pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.